Table 4: Laboratory findings of subjects with and without macrovascular disease.

VariableNo macrovascular disease ()Macrovascular disease () value

White cell count (×109/L)7.09 (5.88–7.87)7.29 (6.42–9.24)0.13
Haemoglobin (g/dL)14.2 (13.3–15.1)14.4 (13.6–15.2)0.48
Platelet count (×109/L)242 (204.5–283.5)239 (206–287)0.78
RDW (%)13 (12.5–13.45)13.1 (12.6–13.8)0.13
MPV (fL)10.95 (10.23–11.5)10.9 (10.1–11.6)0.53
eGFR (mL/min/1.72 m2)87.76 ± 22.2193.58 ± 26.00.19
Total cholesterol (mmol/L)4.14 (3.65–5.25)4.1 (3.53–5.11)0.80
HDL cholesterol (mmol/L)1.32 (1.1–1.58)1.24 (1.04–1.46)0.07
LDL cholesterol (mmol/L)2.3 (1.65–3.36)2.18 (1.7–3.13)0.81
Non-HDL cholesterol (mmol/L)2.74 (2.18–3.86)2.83 (2.29–3.78)0.67
Triglycerides (mmol/L)1.13 (0.91–1.64)1.47 (1.14–1.85)0.03
ALP (mmol/L)66 (52–93)69 (59.25–80)0.89
ALT (mmol/L)22 (17.5–32)24 (18–32.75)0.6
Uric acid (μmol/L)319.56 ± 83.19308.65 ± 78.030.47
ESR (mm 1st hr)13 (7–23)9 (5–17)0.08
FPG (mmol/L)7.14 (6.02–8.53)7.08 (6.23–8.05)0.55
Fructosamine (μmol/L)281 (259.25–305)277 (256–303.5)0.77
HbA1c (%)7.0 (6.3–8.1)6.7 (6.3–7.4)0.23
HbA1c (mmol/L)53 (45–65)50 (45–57)0.23

Values are expressed as mean ± SD or median (IQR). Abbreviations: ALP: alkaline phosphatase; ALT: alanine transaminase; eGFR: estimated glomerular filtration rate; ESR: erythrocyte sedimentation rate; FPG: fasting plasma glucose; HbA1c: glycated haemoglobin; MPV: mean platelet volume; RDW: red blood cell distribution width.